Laurence A. Turka - Chief Scientific Officer at Rubius Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Issuer Symbol
RUBY
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Laurence A. Turka since 09 Feb 2025

Holdings reported by Laurence A. Turka for Rubius Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 143,750 31 Jan 2022 Direct Common Stock
Restricted Stock Units 25,875 31 Jan 2023 Direct Common Stock
Common Stock 18,391 31 Jan 2023 Direct

Transactions reported by Laurence A. Turka for Rubius Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.